Overview
Alan Hartford is a Radiation Oncologist in Exeter, New Hampshire. Dr. Hartford is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Posterior Fossa Tumor, Astrocytoma, and Gastrostomy.
His clinical research consists of co-authoring 53 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Non-Small Cell Lung Cancer (NSCLC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5 Alumni Dr, Exeter, NH 03833
275 Nichols Rd, Fitchburg, MA 01420
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
17 Clinical Trials
Brigham And Women's Hospital, Department Of Radiation Oncology
Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy. He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Brigham And Women's Hospital, Department Of Radiation Oncology
David Kozono is a Radiation Oncologist in Boston, Massachusetts. Dr. Kozono is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
The General Hospital Corporation
Henning Willers is a Radiation Oncologist in Boston, Massachusetts. Dr. Willers is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Willers is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Hartford isDistinguished. Learn about Familial Prostate Cancer.
- Posterior Fossa TumorDr. Hartford isDistinguished. Learn about Posterior Fossa Tumor.
- Prostate CancerDr. Hartford isDistinguished. Learn about Prostate Cancer.
- Advanced
- Adult Soft Tissue SarcomaDr. Hartford isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- AstrocytomaDr. Hartford isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Bone TumorDr. Hartford isAdvanced. Learn about Bone Tumor.
- Brain TumorDr. Hartford isAdvanced. Learn about Brain Tumor.
- Embryonal Tumor with Multilayered Rosettes
- Experienced
- Acoustic NeuromaDr. Hartford isExperienced. Learn about Acoustic Neuroma.
- ALK-Positive Non-Small Cell Lung CancerDr. Hartford isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Hartford isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Anal CancerDr. Hartford isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Hartford isExperienced. Learn about Angiosarcoma.
- Arteriovenous MalformationDr. Hartford isExperienced. Learn about Arteriovenous Malformation.